Test Price
850 AEDโ Home Collection Available
Respiratory Panel 4 Test in UAE โ 850 AED โ DHA Licensed
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via ISO-accredited multiplex qPCR and Whole Genome Sequencing.
- Collection Logistics: VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection available daily 8 AMโ11 PM.
- Clinical Support: Telephonic post-test guidance included with every report.
- Insurance Verification: Direct billing check via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Respiratory Panel 4 Test employs multiplex real-time PCR and Whole Genome Sequencing to simultaneously detect the most clinically relevant respiratory pathogens from a single throat or nasal swab, or sputum specimen. This advanced molecular approach enables rapid differentiation between viral, bacterial, and atypical etiologies, supporting targeted antimicrobial therapy and reducing unnecessary antibiotic use.
| Feature | DNA Labs UAE Respiratory Panel 4 | Conventional Singleplex PCR |
|---|---|---|
| Methodology | Multiplex qPCR + Reflex WGS | Singleplex PCR |
| Turnaround Time | 24โ48 hours | 3โ5 days |
| Sensitivity | 99.9% | 85โ90% |
| Pathogen Coverage | Influenza A/B, RSV, Adenovirus, Mycoplasma pneumoniae, SARS-CoV-2, and atypical strains via WGS | Single-target detection |
| Home Collection | Yes โ ISO-certified cold-chain mobile phlebotomy | Clinic visit required |
| Accreditation | ISO 9001:2015 & DHA Licensed | Varies |
Physician Insight & Safety Protocols
Dr. Ajay Singh | General Practitioner | DHA Registration ID: 36234132
โClinical correlation remains the cornerstone of respiratory diagnostics. A positive PCR signal must always be weighed against the patientโs symptom profile, exposure history, and radiographic findings. The Respiratory Panel 4 supports accurate pathogen identification, which directly informs antibiotic stewardship and antiviral decision-making. Patients should never alter or discontinue a prescribed treatment regimen without prior consultation with their treating clinician.โ
Advisory: Medication Safety
Do not pause, adjust, or stop any prescribed medications โ including antibiotics, antivirals, or antipyretics โ without explicit direction from your treating physician. Abrupt discontinuation may lead to treatment failure, rebound symptoms, or antimicrobial resistance.
Exclusion Criteria & Emergency Red Flags
- This test is not intended for self-diagnosis or replacement of a comprehensive clinical evaluation.
- Seek immediate emergency care if you experience severe respiratory distress, persistent chest pain, confusion, cyanosis (bluish lips or skin), or high fever unresponsive to antipyretics.
- Immunocompromised patients or those on immunosuppressive therapies may require additional diagnostic workup beyond this panel.
Patient FAQ & Clinical Guidance
1. Which respiratory pathogens does this panel detect?
The Respiratory Panel 4 targets Influenza A and B, Respiratory Syncytial Virus, Adenovirus, Mycoplasma pneumoniae, and SARS-CoV-2. When atypical strains are suspected, reflex Whole Genome Sequencing is performed to confirm the pathogen and identify variant lineages.
2. How should I prepare for sample collection?
No fasting or special preparation is required. A trained phlebotomist will collect a throat or nasal swab, or a sputum sample, using a sterile collection kit during your scheduled home visit. Please avoid using mouthwash or nasal sprays for one hour prior to collection.
3. When will I receive my results and how are they delivered?
Results are typically available within 24โ48 hours after the sample is received by the laboratory. You will receive a secure digital report via email or WhatsApp, followed by a telephonic consultation with a clinician to explain the findings and discuss next steps.
4. Can this test distinguish between viral and bacterial infections?
Yes. The panel is designed to differentiate viral pathogens (e.g., Influenza, RSV, SARS-CoV-2) from bacterial and atypical organisms such as Mycoplasma pneumoniae. This distinction is critical for guiding appropriate use of antibiotics versus antiviral therapy.
UAE Regulatory & Data Privacy Adherence
Data Protection & Confidentiality: All patient data is processed and stored in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your clinical information is encrypted, access-controlled, and never shared without explicit consent.
Clinical Safety & Consent: Sample collection and diagnostic procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring that patient safety and informed consent are upheld at every stage of care.
Accreditation: ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | DHA Facility License No. 1143
Clinical & Logistical Metadata
| Test Name | Respiratory Panel 4 Test |
| Price (AED) | 850 AED |
| Turnaround Time | 24โ48 hours |
| Sample Type / Matrix | Throat Swab, Nasal Swab, Sputum |
| Methodology Used | Multiplex Real-Time PCR (qPCR) + Reflex Whole Genome Sequencing |
| ICD-10-CM Code | J06.9, B97.89, U07.1 |
| LOINC Code | 88094-6 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians